# Task B2: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses

> **NIH NIH N01** · UTAH STATE UNIVERSITY · 2020 · $73,572

## Abstract

This contract provides in vitro testing of potential anti-bacterial and anti-fungal agents, efficacy to combat the effects of toxins produced by bacteria and fungi, maintenance of bacterial, fungal and toxin stocks, and the development of related assays.

## Key facts

- **NIH application ID:** 10116213
- **Project number:** 75N93019D00021-P00001-759301900132-1
- **Recipient organization:** UTAH STATE UNIVERSITY
- **Principal Investigator:** CRAIG DAY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $73,572
- **Award type:** —
- **Project period:** 2019-09-13 → 2020-09-12

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10116213

## Citation

> US National Institutes of Health, RePORTER application 10116213, Task B2: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses (75N93019D00021-P00001-759301900132-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10116213. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*